NCT02829333

Brief Summary

The purpose of this study is to verify the effect of anesthetic technique on the change of postoperative serum vascular endothelial growth factor C and prostaglandin E2, and to explore the potential impact of the anesthetic technique on leiomyomas recurrence and growth after the surgery of abdominal myomectomy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 5, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 12, 2016

Completed
Last Updated

January 22, 2020

Status Verified

July 1, 2016

Enrollment Period

11 months

First QC Date

July 5, 2016

Last Update Submit

January 21, 2020

Conditions

Keywords

analgesiaanesthesialeiomyomastumorvascular endothelial growth factoranesthesia technique on tumor

Outcome Measures

Primary Outcomes (2)

  • Change of vascular endothelial growth factor C before anesthesia and at 48 hours after surgery

    Blood samples were sampled before anesthesia and at 48h after surgery for the serum VEGF-C,which were analyzed by using enzyme linked immunosorbent assay (ELISA).

    Before anesthesia and at 48 hours after surgery

  • Change of prostaglandin E2 before anesthesia and at 48 hours after surgery

    Blood samples were sampled before anesthesia and at 48h after surgery for the serum PGE2,which were analyzed by using enzyme linked immunosorbent assay (ELISA).

    Before anesthesia and at 48 hours after surgery

Secondary Outcomes (1)

  • Visual analog scale (VAS) pain scores

    at 2h, 4h, 8h, 12h, 24h and 48h after surgery

Study Arms (2)

Group GA

OTHER

22 patients receive general anesthesia and patient controlled intravenous analgesia

Other: general anesthesia and patient controlled intravenous analgesia

Group SA

OTHER

22 patients receive spinal anesthesia and continuous postoperative epidural analgesia

Other: spinal anesthesia and continuous postoperative epidural analgesia

Interventions

Patients receive general anesthesia intraoperative period and continuous intravenous analgesia postoperation

Group GA

Patients receive spinal anesthesia intraoperative period and continuous epidural analgesia postoperation

Group SA

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patients with leiomyomas requiring abdominal myomectomy, aged 18-65 year and American Society of Anesthesiologists (ASA) physical status I or II.

You may not qualify if:

  • The patients who had a history of surgery within the preceding two weeks, a history of blood transfusion and a history of coronary artery disease, any contraindication to spinal anesthesia or opioid analgesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

MyofibromaAgnosiaLeiomyomaNeoplasms

Interventions

Anesthesia, GeneralAnesthesia, Spinal

Condition Hierarchy (Ancestors)

Neoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeConnective Tissue DiseasesSkin and Connective Tissue DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeoplasms, Muscle Tissue

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and AnalgesiaAnesthesia, Conduction

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2016

First Posted

July 12, 2016

Study Start

May 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

January 22, 2020

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share